CD69 and inflammatory bowel disease: Given these characteristics, the cytokine-complemented model harboring M/DC precursors without RA pre-treatment may mirror the pathological immune activation seen in IBD, characterized by pro-inflammatory monocytes (CD14+CD16+) and elevated T cell activation markers such as CD25 and CD69 (summarized in Table 1).